Pere Barba

6.3k total citations
90 papers, 1.6k citations indexed

About

Pere Barba is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Pere Barba has authored 90 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 45 papers in Oncology and 20 papers in Epidemiology. Recurrent topics in Pere Barba's work include Hematopoietic Stem Cell Transplantation (38 papers), CAR-T cell therapy research (25 papers) and Acute Lymphoblastic Leukemia research (19 papers). Pere Barba is often cited by papers focused on Hematopoietic Stem Cell Transplantation (38 papers), CAR-T cell therapy research (25 papers) and Acute Lymphoblastic Leukemia research (19 papers). Pere Barba collaborates with scholars based in Spain, United States and France. Pere Barba's co-authors include David Valcárcel, Rodrigo Martino, Jorge Sierra, José Luís Piñana, Salut Brunet, Javier Briones, Anna Sureda, Guillermo Ortí, Julio Delgado and Gloria Iacoboni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Pere Barba

85 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pere Barba Spain	24	826	709	264	256	226	90	1.6k
Marta González‐Vicent Spain	26	633 0.8×	1.0k 1.4×	262 1.0×	368 1.4×	504 2.2×	133	2.0k
Atsushi Makimoto Japan	22	478 0.6×	619 0.9×	157 0.6×	212 0.8×	286 1.3×	91	1.5k
Shigeo Fuji Japan	24	536 0.6×	920 1.3×	213 0.8×	204 0.8×	672 3.0×	151	1.9k
Shigesaburo Miyakoshi Japan	26	596 0.7×	982 1.4×	210 0.8×	416 1.6×	370 1.6×	90	1.7k
Matthew Carabasi United States	15	910 1.1×	682 1.0×	167 0.6×	501 2.0×	549 2.4×	47	1.7k
Prakash Satwani United States	28	550 0.7×	1.0k 1.5×	325 1.2×	268 1.0×	474 2.1×	138	2.1k
Hideki Nakasone Japan	24	477 0.6×	956 1.3×	192 0.7×	478 1.9×	379 1.7×	158	1.7k
Francesco Fabbiano Italy	18	693 0.8×	552 0.8×	428 1.6×	294 1.1×	69 0.3×	47	1.6k
Edward Kanfer United Kingdom	26	477 0.6×	1.1k 1.6×	250 0.9×	206 0.8×	416 1.8×	55	1.8k
Kazuko Kudo Japan	30	631 0.8×	1.3k 1.9×	452 1.7×	335 1.3×	406 1.8×	102	2.4k

Countries citing papers authored by Pere Barba

Since Specialization

Citations

This map shows the geographic impact of Pere Barba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Barba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Barba more than expected).

Fields of papers citing papers by Pere Barba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pere Barba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Barba. The network helps show where Pere Barba may publish in the future.

Co-authorship network of co-authors of Pere Barba

This figure shows the co-authorship network connecting the top 25 collaborators of Pere Barba. A scholar is included among the top collaborators of Pere Barba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pere Barba. Pere Barba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camacho-Arteaga, Lina, Gloria Iacoboni, Mi Kwon, et al.. (2025). Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma. JAMA Network Open. 8(2). e2461683–e2461683.

Iacoboni, Gloria, Sheila Bermejo, Cecilia Carpio, et al.. (2024). Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies. Clinical Kidney Journal. 17(3). sfae027–sfae027. 12 indexed citations

Rejeski, Kai, Yucai Wang, Omar Albanyan, et al.. (2023). The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL. American Journal of Hematology. 98(11). 1699–1710. 17 indexed citations

Socié, Gèrard, Pere Barba, Arie Barlev, et al.. (2023). Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. Bone Marrow Transplantation. 59(1). 52–58. 9 indexed citations

Solano, Carlos, Pedro Castro, Antonio Pérez‐Martínez, et al.. (2023). Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study. BMJ Open. 13(7). e071371–e071371. 2 indexed citations

Ribera, Jordi, Isabel Granada, Mireia Morgades, et al.. (2021). Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols. British Journal of Haematology. 196(3). 670–675. 6 indexed citations

Fox, María Laura, Irene García‐Cadenas, Ariadna Pérez, et al.. (2020). Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis. Leukemia & lymphoma. 61(8). 1823–1832. 2 indexed citations

Roldán, Elisa, Miguel‐Angel Perales, & Pere Barba. (2019). Allogeneic Stem Cell Transplantation with CD34+ Cell Selection. SHILAP Revista de lepidopterología. 1(3). 154–160. 3 indexed citations

Barba, Pere, Rodrigo Martino, Qin Zhou, et al.. (2018). CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 24(5). 964–972. 16 indexed citations

10.

Barata, Anna, Rodrigo Martino, Ignasi Gich, et al.. (2017). Do Patients and Physicians Agree When They Assess Quality of Life?. Biology of Blood and Marrow Transplantation. 23(6). 1005–1010. 6 indexed citations

11.

García‐Cadenas, Irene, Cristina Díaz de Heredia, Rodrigo Martino, et al.. (2016). Cord Blood Units with High CD3+ Cell Counts Predict Early Lymphocyte Recovery After In Vivo T Cell–Depleted Single Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 22(6). 1073–1079. 11 indexed citations

12.

Ortí, Guillermo, Pere Barba, María Laura Fox, et al.. (2016). Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect. Experimental Hematology. 48. 1–11. 49 indexed citations

13.

Kharfan‐Dabaja, Mohamed A., Rocío Parody, Janelle Perkins, et al.. (2016). Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation. Bone Marrow Transplantation. 52(3). 438–444. 8 indexed citations

14.

Gallardo, David, José González‐Campos, Jesús María Hernández‐Rivas, et al.. (2015). Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy. Leukemia & lymphoma. 57(1). 86–91. 11 indexed citations

15.

Fox, María Laura, Pere Barba, Inmaculada Heras, et al.. (2014). A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation. Clinical Microbiology and Infection. 21(1). e1–e3. 11 indexed citations

16.

Ruíz-Camps, Isabel, et al.. (2014). Clinical usefulness of therapeutic drug monitoring of voriconazole in a university hospital. Enfermedades Infecciosas y Microbiología Clínica. 33(5). 298–302. 18 indexed citations

17.

Barba, Pere, Rodrigo Martino, Josè Antonio Pérez-Simón, et al.. (2013). Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(1). 66–72. 32 indexed citations

18.

Piñana, José Luís, Pau Montesinos, Rodrigo Martino, et al.. (2013). Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients. Annals of Hematology. 93(2). 299–307. 32 indexed citations

19.

Barba, Pere, José Luís Piñana, David Valcárcel, et al.. (2009). Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 15(11). 1439–1446. 55 indexed citations

20.

Piñana, José Luís, David Valcárcel, Rodrigo Martino, et al.. (2009). Study of Kidney Function Impairment after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. A Single-Center Experience. Biology of Blood and Marrow Transplantation. 15(1). 21–29. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact